Results
Literature and observed clinical data confirm the variability in
clinical responses in COVID-19 when treated with the same fixed doses.
Confounding factors were identified that should be taken into account
for dose recommendation. For 80% of patients, doses higher than 800mg
day on D1 followed by 600mg daily on following days might not be needed
for being cured. Limited adverse drug reactions have been reported so
far for this dosing regimen, most often confounded by co-medications,
comorbidities or underlying COVID-19 disease effects.